Top Markets
#1 DogBull DogBull +54.73%
#2 Siren Siren +30.85%
#3 OriginTrail OriginTrail +22.47%
#4 Yield Basis Yield Basis +13.33%
#5 龙虾 (Lobster) 龙虾 (Lobster) +11.09%
#6 Purr Purr +10.17%
#7 Cysic Cysic +9.76%
#8 COTI COTI +9.02%
#9 Stargate Finance Stargate Finance +8.63%
#10 Ethena Staked ENA Ethena Staked ENA +7.12%
Coin of the day
DogBull DogBull
Settings
Language
ENGLISH
Currency
USD
Theme
ABIONYX Pharma S.A. ABIONYX Pharma S.A.

ABIONYX Pharma S.A.

ABNX
Rank in Stocks #21916
ABIONYX Pharma SA is a biotechnology company dedicated to the identification... ABIONYX Pharma SA is a biotechnology company dedicated to the identification and advancement of therapies for conditions affecting the kidneys and eyes. The firm's pipeline includes CER-001, an innovative negatively-charged lipoprotein particle. This compound is designed to mimic the structural and functional attributes of pre-beta HDL, utilizing human recombinant apoA-I (a natural high-density lipoprotein protein) along with natural phospholipids like sphingomyelin and dipalmitoylphosphatidylglycerol. CER-001 is currently under development for patients recovering from acute coronary syndrome and those with familial primary hypoalphalipoproteinemia. Another key candidate, CER-002, is a specific agonist for peroxisome proliferator-activated receptor delta, targeting cardiovascular and metabolic diseases. Additionally, CER-209 is being developed as a potential treatment for metabolic liver diseases, atherosclerosis, and non-alcoholic steatohepatitis (NASH). ABIONYX maintains strategic partnerships with GTP Biologics and VBI Therapeutics Group for the bioproduction of its bio-HDL in France. Established in 2005, the company operated as Cerenis Therapeutics Holding SA before its rebranding to ABIONYX Pharma SA in August 2019. Its operations are headquartered in Balma, France.
Share Price
$2.32
Last synced: 2026-08-21
Market Cap
$98.03M
Change (1 day)
-1.91%
Change (1 year)
-5.84%
Country
FR
Trade ABIONYX Pharma S.A. (ABNX)

Category

Healthcare
Dividend history for ABIONYX Pharma S.A. (ABNX)
ABIONYX Pharma S.A. (stock symbol: ABNX) made a total of 0 dividend payments.
The sum of all dividends (adjusted for stock splits) is : 0.00
Dividend yield (TTM) : 0
Dividend payments for ABIONYX Pharma S.A. (ABNX) from 2026 to 2026
Annual dividend payments
Year Dividend (stock split adjusted) Change
Not enough data for the provided dates.
List of all dividend payments
Year Dividend Change
Not enough data for the provided dates.
Dividend payments for similar companies or competitors
Company Number of dividend payments Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH